Visicell Announces Closing of Convertible Note Financing

Visicell Medical Inc. had successfully closed the oversubscribed $1 million dollars convertible note offering led by industry expert Life Science Angeles, as well as investment from Harmonix, an early-stage venture capital fund. Visicell is also honored to have the support of angel investors from the San Diego community, where Visicell was a runner-up among 105 companies competing in the second annual San Diego Angel Conference.

The fund will help support Visicell's vision "GPS for cell therapy" that will offer real-time insight to patients, doctors, and researchers on product performances as well as accelerate development of cell therapy from laboratory to market.

-Visicell Medical Team